Cardiovascular diseases are the #1 cause of death globally and result in €210B in annual costs for EU health insurers. 

Based on clinical evidence, we develop a highly scalable ML-powered medical analytics platform that integrates smart biosensors, cardiac monitoring software, and a mobile app for patients. Analyzing the data of 30,000 cardiovascular patients per month, we are continuously refining our Deep Learning prediction modules and validating their core in a clinical trial at the end of the year. In addition to brand new reimbursement opportunities, we are pursuing a ‘beyond-the-pill’ business model with leading pharma firms.